DISCOVER
Screener
Stocks
ETF
Crypto
SCPI
Trending
Comparator
Calendar
Charting
Super investors
SOCIAL
Community
Public portfolios
Search an asset or a profile
/
Image Modal
Image Modal Description
Eli Lilly and Company
LLY
-
US5324571083
Compare
Last update : Jun 19, 2026 at 22:45
General
Scores
Financials
Ratios
Valuation
Dividend
Exposure
Analysts
Insider
Eli Lilly and Company (LLY) Business Breakdown and KPIs - Invvest
Settings
Period
5 years
10 years
Max
Customization
Line
Bar
Percentage
Value
Labels
Growth YoY
Sections
Segments
KPIs
Segments
Revenue
Immunology Revenue
Cardiovascular Revenue
Trulicity Revenue
Basaglar Revenue
Humalog Revenue
Glucagon Revenue
Others
CAGR
Variation 10 years
Immunology Revenue
+3.32%
+38.65%
Cardiovascular Revenue
+0.59%
+6.07%
Trulicity Revenue
+0.49%
+5.04%
Basaglar Revenue
+2.99%
+34.28%
Humalog Revenue
+1.45%
+15.44%
Glucagon Revenue
+2.78%
+31.53%
Others
-0.27%
-2.68%
Revenue by Geography
Japan Revenue
China Revenue
Other Foreign Countries Revenue
Europe Revenue
US Revenue
CAGR
Variation 10 years
Japan Revenue
+2.13%
+23.48%
China Revenue
+2.39%
+26.61%
Other Foreign Countries Revenue
+0.96%
+10.07%
Europe Revenue
-1.17%
-11.11%
US Revenue
-0.29%
-2.9%
KPIs
Revenue Change due to Price
Revenue Change due to Price
CAGR
Variation 10 years
Revenue Change due to Price
-1.81%
-16.66%
Revenue Change due to Volume
Revenue Change due to Volume
CAGR
Variation 10 years
Revenue Change due to Volume
-1.33%
-12.57%
Revenue Change due to FX
Revenue Change due to FX
CAGR
Variation 10 years
Revenue Change due to FX
-2.3%
-20.75%
